February Newsletter
FDA Approves Important Drug for Dry Macular Degeneration A Note from Dr. Najarian: “This is an exciting new therapy to offer our patients with a form of dry macular degeneration, which is unfortunately all too common. Prior to the introduction of this new class of medicine, our only treatments included close observation, taking AREDS 2 vitamins, […]
Read More